OLIMAB 60MG
DESCRIPTION:
Olimab 60mg is a human monoclonal antibody for the treatment of osteoporosis, convinced bone loss, bone metastases and giant cell tumor. Olimab 60mg injection is contraindicated in people with low calcium in the blood.Olimab 60mg is a prescription drug that is used under the guidance of the oncologist.
INDICATION:
• Suitable for the treatment of osteoporosis in postmenopausal women at high risk (end of menopause / life change), whose serious fracture problems have been raised or have failed other osteoporosis drugs.• Suitable for the treatment of breast cancer in women whose treatment is safe, which makes their risk of fractures and bone loss in men with prostate cancer serious.
• It is indicated for treatment in adults and other adolescents with a giant giant cell tumor that cannot be treated with surgery is not possible with Olimab 60mg injection .
ACTION MECHANISM:
The Denosumab ( Olimab 60mg injection ) mechanism , targeting a protein called RANKL, which is required for new osteoclasts to be made and functioning. This promotes subsequent inhibition of bone decomposition and reduces the risk of secondary bone cancer problems such as fractures. It can also help reduce the pain caused by secondary bone cancer.PRODUCT DETAILS:
Brand: OlimabIngrediente: Denosumab
Forța: 60mg
Fabricat: Intas Pharmaceuticals
Package: 1 injection in a pre-filled syringe
Price: olimab 60mg price in india
 |
olimab 60mg |
Adna
• Maximum plasma concentration: 6.75mcg / ml• Tmax: 10 days
• No aggregation in long-term pharmacokinetic Olimab was observed at multiple dosing of 60 mg SC given every 6 months.
• The pharmacokinetics of Olimab 60mg injection will not be affected by the formation of binding antibodies.
• The half-life is 25.4 days.
DOSAGE MANAGEMENT:
For adults:The prescribed dose for Osteoporosis is olimab 60mg SC (subcutaneously) every 6 months
Administer the injection into the upper arm, upper thigh, or abdomen
The prescribed dose for androgen deprivation-induced bone loss is olimab 60mg SC q6months injection .
The prescribed dose is Olimab 60mg glucocorticoid-induced injection olimab 60mg SC q6months.
The prescribed dose is the aromatase inhibitor bone loss olimab 60 mg SC injection q6months
For the children:
The prescribed dose is 13 years and above and 45 kg or more for Giant Bone Cell Tumor: The recommended dose is 120 mg Olimab 60 mg tablet administered SC, with additional doses of 120 mg on days 8 and 15 of the first month of treatment in 4 weeks.
OVERDOSE:
There is no experience of overdose of Olimab 60mg injection . If it occurs, take the patient to the emergency department and call for poison controlPrecautions:
• Before starting denosumab it should be corrected. Hypocalcemia can worsen, especially in patients with renal impairment. Sufficiently supplements patients with calcium and vitamin D.• Olimab 60mg injection has negative effects on immuno-suppressors can improve. Especially the damage of severe infections can be high. Talk to your doctor about any immunosuppressive medicines you take early.
• Do not take any type of vaccination without consulting your doctor while administering denosumab.
• While treatment with Olimab has Osteonecrosis of the jaw (ONJ) has been reported with denosumab - check the symptoms.
• If you are planning to become pregnant before starting this therapy, consult your doctor before treatment, as use during pregnancy only if the benefit to the mother outweighs the risk of the fetus).
SIDE EFFECTS:
Common side effects for the patient taking Olimab 60mg injection :• Nausea
• Fatigue
• Muscle weakness
• Hypophosphataemia.
Uncommon side effects for patients taking Olimab 60 mg :
• Diarrhea
• Shortness of breath
• Hypocalcemie
• Joint pain
• Hypocalcemie
• Cough
• Artralgie
• Pain of the limbs
• Eczema
• Headache
• Eczema
• Eczema
 |
| osteoporosis |
DRUG INTERACTION:
There is no formal drug-drug interaction with denosumab during the studies.When used concomitantly with some anticancer drugs, orthopedic drugs, vaccines will lead to increased risk of adverse effects
CONTRAINDICATIONS:
Olimab 60mg injection is contraindicated inhypocalcemie
pregnancy
Hypersensitivity
PREGNANCY:
category COlimab 60 mg , which does not have sufficient data in pregnant women to transmit any risk of analogue drug for adverse drug development in pregnant women, is contraindicated for use as it may cause a serious risk to the fetus.
Lactation:
Olimab 60mg injection in human milk. As it is possible for severe side effects, it appears in infants who are breast - fed with Olimab 60 mg injection . Avoid breast-feeding during treatment with Denosumab.STORAGE:
Store at 2 ° C to 8 ° C in the original container.Avoid freezing.
Before administration, keep at room temperature.
Olimab 60mg protects against direct light and heat.
DOSAGE missed:
If the dose is missed, then dose immediately before the next dose. The next dose duration then reaches the missed missed dose and follows the regular schedule. Avoid taking double doses at the same time.Please consult your doctor for further information.
Comments
Post a Comment